@article{43034cd0d55749e4a8e8a7c6426f11b6,
title = "The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection",
author = "Bartlett, \{John G.\}",
note = "Funding Information: Potential conflicts of interests. J.G.B. has served on the HIV Advisory Boards of Johnson \& Johnson, Bristol Myers Squibb, Gilead, Tibotec, GlaxoSmithKline, and Pfizer, has served on the Infectious Diseases Advisory Board of Arpida, and has received a research grant from Gilead.",
year = "2008",
month = may,
day = "15",
doi = "10.1086/587654",
language = "English (US)",
volume = "46",
pages = "1489--1492",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "10",
}